Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rubius Therapeutics
Biotech
The 2023 Biotech Graveyard
Nearly four times as many companies entered the biotech graveyard in 2023 compared to 2022.
Max Bayer
,
Gabrielle Masson
Oct 31, 2023 6:00am
Ex-Rubius CEO goes to Incyte—Chutes & Ladders
May 12, 2023 9:30am
After last-ditch effort, Rubius moves to dissolve
Feb 22, 2023 9:55am
Former Roche pharma head to be new Bayer CEO—Chutes & Ladders
Feb 10, 2023 9:30am
UPDATE: Flagship's Repertoire reveals culls, cuts and new CEO
Nov 7, 2022 10:47am
Rubius execs depart as the walls close in—Chutes & Ladders
Nov 4, 2022 9:30am
